Physician profile
David Guerra
NPI 1669560926
$1,949.35
in general payments reported to CMS, 2019-2025
24 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $211 · 2021: $313 · 2022: $222 · 2023: $518 · 2024: $389 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $725.56 | 2020-2024 | Da Vinci Surgical System |
| Indivior INC. | $241.11 | 2019-2022 | |
| Abbvie INC. | $197.66 | 2019-2023 | |
| Hologic Sales and Service, LLC | $91.29 | 2020-2025 | Thinprep 2000 Processor, Aptima |
| Roche Diagnostics Corporation | $82.11 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $71.90 | 2023-2024 | |
| Axonics, INC. | $65.47 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.37 | 2020-2025 | |
| Evofem Biosciences, INC. | $55.64 | 2021-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $43.11 | 2021-2024 | |
| Avion Pharmaceuticals | $42.44 | 2019-2022 | |
| Ethicon US, LLC | $38.79 | 2021-2022 | |
| Novo Nordisk INC | $36.68 | 2025 | Wegovy |
| Exeltis, USA INC. | $34.62 | 2022-2023 | Slynd |
| Becton, Dickinson and Company | $27.96 | 2023-2024 | Bd Onclarity |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $22.07 | 2024 | Veozah |
| Pfizer INC. | $19.65 | 2023 | |
| Bio Products Laboratory USA, INC. | $16.72 | 2021 | |
| Merck Sharp & Dohme LLC | $15.84 | 2021 | |
| Myovant Sciences INC. | $13.54 | 2022 | |
| Qiagen, LLC | $13.49 | 2025 | |
| Therapeuticsmd, INC. | $12.43 | 2019 | |
| Lupin INC. | $11.99 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Guerra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.